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ABSTRACT
This study examined the establishment of neutrophilic
inflammation in humans. We tested the hypotheses that
neutrophil recruitment was associated with local
CXCL8 production and that neutrophils themselves
might contribute to the regulation of the size of the in-
flammatory response. Humans were challenged i.d.
with endotoxin. Biopsies of these sites were examined
for cytokine production and leukocyte recruitment by
qPCR and IHC. Additional in vitro models of inflamma-
tion examined the ability of neutrophils to produce
and sequester cytokines relevant to neutrophilic in-
flammation. i.d. challenge with 15 ng of a TLR4-selec-
tive endotoxin caused a local inflammatory response,
in which 1% of the total biopsy area stained positive
for neutrophils at 6 h, correlating with 100-fold up-
regulation in local CXCL8 mRNA generation. Neutro-
phils themselves were the major source of the early
cytokine IL-1. In vitro, neutrophils mediated CXCL8
but not IL-1 clearance (90% clearance of 2 nM
CXCL8 over 24 h). CXCL8 clearance was at least par-
tially receptor-dependent and modified by inflamma-
tory context, preserved in models of viral infection but
reduced in models of bacterial infection. In conclu-
sion, in a human inflammatory model, neutrophils are
rapidly recruited and may regulate the size and out-
come of the inflammatory response through the up-
take and release of cytokines and chemokines in pat-
terns dependent on the underlying inflammatory stim-
ulus. J. Leukoc. Biol. 93: 7–19; 2013.
Introduction
Neutrophilic inflammation is usually essential in the control of
established bacterial infection but is also an important compo-
nent of numerous disease processes in many organs. Neutro-
phil trafficking to inflamed tissues is generally held to be me-
diated through the local production of chemokines of the
CXC family, whose production is directly induced by stimuli
such as LPS or lies downstream of early proinflammatory cyto-
kines such as IL-1. However, other patterns of mediator gener-
ation causing neutrophil recruitment have been described in
animals, such as complement activation preceding chemokine
generation [1] or leukotriene production causing tissue neu-
trophilia [2].
Neutrophil recruitment is tightly regulated and is rapidly
terminated before the inflammatory response has resolved and
even before maximal activation of neutrophils has been
achieved [3, 4]. Mechanisms causing defervescence of the in-
flammatory site are relatively well explored and include induc-
tion of apoptosis and production of anti-inflammatory re-
solvins and cytokines. These key components of inflammatory
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resolution are later events in the life of an inflammatory focus
and do not immediately explain how the rapid termination of
neutrophil recruitment occurs. The mechanisms matching lev-
els of recruitment to the size of the insult remain poorly un-
derstood.
Using in vitro models, we demonstrated previously that in-
duction of CXCL8 in response to bacterial stimuli was best
mediated when tissue cells were cocultured with monocytes in
a network where monocytes initiated responses through IL-1
production [5–7]. Here, we sought to establish a human
model to investigate the relationship between IL-1 and CXCL8
production and neutrophil recruitment in response to endo-
toxin and used in vitro models to study how the magnitude of
neutrophil recruitment may be determined.
MATERIALS AND METHODS
Ethics
Studies were approved by the Sheffield Research Ethics Committee (UK)
and required informed written consent in accordance with the Declaration
of Helsinki. Inclusion criteria for the i.d. study were healthy volunteers of
either sex and any race, aged 18–50. The i.d. endotoxin study was overseen
by a data-monitoring group, independent of the principal investigators.
Experiments using mice were approved by the Institutional Animal Care
and Use Committee of the University of Maryland, Baltimore (USA). Mice
were killed prior to carrying out peritoneal lavage to collect primary macro-
phages.
Reagents
poly(I:C) was from Invivogen (San Diego, CA, USA). General lab reagents
were from Sigma-Aldrich (Poole, Dorset, UK). Cell culture reagents were
from Invitrogen (Paisley, Renfrewshire, UK).
i.d. endotoxin challenge
A total of 13 healthy volunteers received four to six i.d. injections (one of
saline; the remainder of endotoxin) in the volar surfaces of their forearms
at the start of the study. The endotoxin was Escherichia coli strain O:113
{NIH reference stock for clinical trials (Bethesda, MD, USA); a kind gift of
Dr. Anthony Suffredini [8]}. The study was divided into an ascending dose
phase in eight individuals studied sequentially to safely establish optimal
dosing and a second phase using a standardized protocol in five individuals
to achieve statistically testable data. Skin sites were measured for area of
redness, capturing the outline with sticky tape and quantifying the area us-
ing NIH ImageJ. Relevant physiological parameters (blood pressure, tem-
perature, pulse rate) were measured regularly and blood sampled for CRP,
hematological parameters, and cytokine analysis. At indicated time-points,
the skin sites were anesthetized by the s.c. injection of 1% lignocaine con-
taining adrenaline and 4 mm punch biopsies taken. Biopsies were divided
and one-half of each placed into formaldehyde or RNAlater (Ambion, Aus-
tin, TX, USA).
IHC
Sections (5 m) were stained with antibodies to neutrophil elastase (Dako,
Glostrup, Denmark) and IL-1 (Abcam, Cambridge, UK). Binding was de-
tected using a Vectastain Elite ABC kit (Vector Laboratories, Peterborough,
UK) and a Vector NovaRed substrate kit. Sections were counterstained with
hematoxylin, dehydrated to xylene, and mounted in DPX. Staining was an-
alyzed using the Dako Automated Cellular Imaging System (ACIS) III auto-
mated image acquisition and analysis system. Thresholds of detection were
chosen for each antibody after examination of initial samples, such that all
dense staining cells were identified without identification of nonstaining
cells (judged by investigators A.B. and L.B.).
qPCR
RNA was extracted from skin biopsies using a TissueRuptor (Qiagen,
Crawley, UK) and the RNeasy Lipid Tissue Mini Kit (Qiagen). cDNA
was synthesized using the high-capacity cDNA RT kit (Applied Biosys-
tems, Paisley, UK).
qPCR was carried out using assay probe sets specific for IL-1, IL-1,
and CXCL8 (Applied Biosystems), and reaction mixtures were prepared as
described previously [9]. Reactions were carried out using an ABI7900 Au-
tomated TaqMan (Applied Biosystems), and absolute copy number was
quantified against standards of plasmids (SourceBioscience, Nottingham,
UK) containing the target sequences to be amplified.
Leukocyte preparation
Highly purified human neutrophils were prepared from the venous blood
of healthy volunteers by density gradient centrifugation and negative mag-
netic selection using a custom cocktail from Stem Cell Technologies (Van-
couver, Canada) as described [10]. Monocytes were prepared from PBMC
fractions by negative magnetic selection using the Monocyte Isolation Kit II
(Miltenyi Biotec, Audburn, CA, USA) as described [9]. Neutrophils and
monocytes were cocultured with BEAS-2B epithelial cells or cultured in iso-
lation in tissue-culture plates, with or without the addition of indicated cy-
tokines (PeproTech EC, London, UK).
To obtain primary murine peritoneal macrophages, WT C57BL/6J
mice (The Jackson Laboratory, Bar Harbor, ME, USA) or TLR4/
mice (kindly provided by Dr. S. Akira, Osaka, Japan; bred at the Univer-
sity of Maryland, Baltimore) were injected i.p. with thioglycollate broth
as described [11]. Four days later, peritoneal exudates were collected by
lavage, washed, and resuspended in RPMI 1640/2% FBS as described
[11]. Cells were plated at 2  106 cells/ml in 12-well plates and incu-
bated overnight at 37°C. Wells were washed to remove nonadherent cell
types and the medium replaced with medium only, NIH endotoxin, or
the TLR4-specific positive control, E. coli K235 LPS [12, 13]. Macro-
phage cultures were incubated for 2 h and RNA prepared for analysis of
specific cytokine mRNA by qPCR as described [11].
Cell lines
BEAS-2B epithelial cells were maintained in RPMI/10% FCS. Cocultures of
leukocytes and tissue cells were carried out as described previously [6, 9,
14]. Media were harvested for cytokine analysis.
Cytokine, leukocyte, and serological analysis
Cytokines in supernatants were measured by matched antibody pair ELISAs
(R&D Systems, Abingdon, UK) at optimized concentrations and previously
noted LDs [9]. Data were analyzed using GraphPad Prism 5 (GraphPad
Software, La Jolla, CA, USA). Samples whose cytokine levels were below the
LD were assigned the LD value for analysis. Cytokine levels in serum from
volunteers in the i.d. endotoxin study were measured by sensitive multiplex
immunoassays (Meso Scale Discovery, Gaithersburg, MD, USA). Cortisol
levels were measured using routine clinical analyzers and protocols in a
NHS clinical laboratory, as were full blood counts.
Western blotting
Cell lysates were prepared from 0.5  106 neutrophils/point and analyzed
as described [15]. Blots were probed with anti-IL-1 (R&D Systems) and
anti-p38 (Cell Signaling Technology, Hitchin, UK) and an appropriate sec-
ondary antibody. Amersham ECL Western blotting detection reagents (Am-
ersham Pharmacia Biotech, Little Chalfont, UK) were used. Images were
scanned using a Bio-Rad ChemiDoc XRS (Hemel Hempstead, UK) and
quantified using ImageLab V3.0.
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Statistics
Data were analyzed using GraphPad Prism v5, with the tests indicated in
each figure legend, assuming P  0.05 as demonstrating statistical signifi-
cance.
RESULTS
Human i.d. endotoxin challenge
A preparation of E. coli O:113 endotoxic LPS for use in clinical
studies was obtained [8]. Its preparation had been prior to the
realization that low amounts of bacterial lipopeptide com-
monly present in endotoxin preparations deliver a TLR2-acti-
vating signal in addition to the TLR4-activating LPS signal
[12]. We examined whether this NIH preparation to be used
in the clinical study activated TLR4 or TLR2 and TLR4 and
compared it with a highly purified preparation of E. coli K235
LPS that lacks TLR2 stimulatory activity [12]. Macrophage cul-
tures were prepared from WT mice or mice with a targeted
mutation in TLR4 (TLR4/). Both LPS species induced
TNF- (MyD88-dependent), IFN-, and CCL5 (MyD88-inde-
pendent) mRNA in WT macrophages, but no cytokine mRNA
expression was detected in TLR4/ macrophages (Fig. 1),
showing that the NIH clinical endotoxin preparation specifi-
cally activated TLR4.
The experimental examination of human skin responses to
endotoxin has only been performed rarely and lastly, as far as
we could determine, prior to the discovery of cytokines and
TLRs [16]. Thus, we initially studied eight volunteers in an
ascending dose-phase protocol with intervals for assessment of
cellular responses, safety, and tolerability. Alexander Basran
was trained in i.d. injections and skin biopsies. During this
phase, volunteers received endotoxin doses from 10 pg–15 ng/
site, with total doses ranging from 1.1 ng to 45 ng/volunteer.
Biopsies were taken at various predetermined time-points to
observe recruitment kinetics, mostly within 6 h of endotoxin
administration, although in two subjects, biopsies were taken
at 24 h. Blood pressure, pulse, and temperature were moni-
tored routinely at regular intervals during the study. Sutures
were removed by the study team at 8–10 days. Subjects were
encouraged to report any adverse events. A monitoring group
independent of the investigators oversaw progress. No adverse
effects deemed to be related to systemic effects of endotoxin
were observed in any volunteer. CRP did not rise in any volun-
teer but was only monitored until the last biopsy. CRP has a
relative lag in its response. The two volunteers who had biop-
sies and blood sampling at 24 h and received a total dose of
45 ng endotoxin each also showed no rise in CRP at this later
time-point. The highest endotoxin dose tested, 15 ng/site,
caused painless erythema after 1–2 h with mild edema. Based
on these studies, five further volunteers received a standard-
ized regime of one saline injection and two injections each of
5 ng and 15 ng endotoxin. For reasons of clarity and brevity,
data are henceforward shown for the n  5 only, with data
held on file for all of those in the ascending dose phase.
Biopsies (one of each endotoxin dose) were taken at 2 and
6 h. The saline site was biopsied at 6 h. Table 1 shows the
physiological parameters monitored. No significant adverse
effects of endotoxin challenge were observed. Figure 2
shows representative photographs of the inflammatory le-
sions in one subject and mean data for erythema areas ob-
tained from the standardized n  5.
i.d. endotoxin induces tissue and blood neutrophilia
Endotoxin, but not saline, induced rapid recruitment of cells
staining positively for the neutrophil marker, NE, with the typi-
Figure 1. TLR dependence of endotoxin. Macrophages from WT or
TLR4/ mice were pooled from peritoneal lavages and treated with
the indicated concentrations of NIH LPS (N LPS) used in the human
challenge studies or a purified laboratory endotoxin known to activate
TLR4 alone (C LPS). Samples were cultured for 2 h, and generation
of mRNAs for the indicated cytokines was measured by qPCR. (A)
TNF-; (B) IFN-; (C) CCL5. Cells were pooled from multiple mice
(typically five/group), and data shown were derived from a representa-
tive experiment.
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cal PMN appearance of neutrophils (Fig. 3). As neutrophil
recruitment occurred focally across the biopsies, sections were
quantified by automated analysis, where the staining of NE was
quantified on the entire section of each of two separate sec-
tions/biopsy and averaged within and then between donors.
We observed significant time-dependent neutrophil recruit-
ment in response to the 15 ng/site dose (Fig. 3). The only
detectable systemic response to i.d. endotoxin was a variable
blood neutrophilia (Table 1). Serum cortisol declined in each
volunteer over the course of the day (Table 1), in keeping
with natural diurnal variation in cortisol levels (injections were
performed in the morning) and providing further evidence of
a lack of a generalized systemic reaction.
Cytokine generation associated with endotoxin
challenge
As i.d. endotoxin challenge was associated with tissue and
blood neutrophilia, we determined the patterns of cytokine
generation associated with these responses. Sera from the five
donors who received 40 ng total endotoxin each in the stan-
dardized protocol were analyzed by sensitive multiplex immu-
noassays. No significant changes in IL-1, TNF-, IL-6, CXCL8,
or G-CSF were seen in serum (Fig. 4). In contrast, analysis of
gene expression in skin biopsies by qPCR revealed a rapid lo-
cal generation of CXCL8 mRNA, which peaked at 2 h (P0.01
for 5 ng dose and0.001 for 15 ng dose) and had diminished,
although not resolved, by 6 h. Expression of IL-1 and IL-1
(classical early cytokines associated with induction of inflam-
mation) was also evident (Fig. 5). IL-1 expression was only
increased significantly at the 6-h time-point for the 15-ng dose.
IL-1 expression was increased significantly at 2 h (5 ng,
P0.05; 15 ng, P0.01) and 6 h (15 ng, P0.05). Biopsies
were stained for production of IL-1 by IHC (Fig. 6). IL-1
protein expression appeared over a similar time course to its
mRNA expression, coinciding with the arrival of neutrophils in
the tissue. IL-1-producing cells showed the clear nuclear fea-
tures of neutrophils, although analysis of the IHC by visual
inspection and automated analysis demonstrates that IL-1
TABLE 1. Individual Monitoring Parameters
Volunteer code Time (h) 0 1 6
S1 Leukocytes (109/l) 5.8 6.3 8.0
Neutrophils (109/l) 3.5 4.4 5.7
CRP (mg/l) 3.6 NA 4.4
Cortisol (nM) 617 NA 320
Blood pressure (mmHg, systolic/diastolic) 136/84 137/77 136/82
Heart rate (per min) 68 67 69
Temperature (°C) 36.9 36.7 36.9
J1 Leukocytes (109/l) 7.7 8.7 11.2
Neutrophils (109/l) 5.1 5.6 7.8
CRP (mg/l) 7.4 7.2 6.3
Cortisol (nM) 387 NA 184
Blood pressure (mmHg, systolic/diastolic) 138/86 129/75 126/70
Heart rate (per min) 90 74 72
Temperature (°C) 36.7 36.8 36.6
A2 Leukocytes (109/l) 3.8 4.4 9.5
Neutrophils (109/l) 1.9 2.4 7.8
CRP (mg/l) 5 5.1 4
Cortisol (nM) 372 NA 259
Blood pressure (mmHg, systolic/diastolic) 129/92 125/69 113/69
Heart rate (per min) 67 62 61
Temperature (°C) 35.8 35.9 36.5
Q1 Leukocytes (109/l) 6.1 7.7 8.3
Neutrophils (109/l) 5.1 6.4 6.3
CRP (mg/l) 1.9 2.1 2
Cortisol (nM) NA NA NA
Blood pressure (mmHg, systolic/diastolic) 115/69 114/65 118/69
Heart rate (per min) 57 55 61
Temperature (°C) 36.8 36.7 36.9
L4 Leukocytes (109/l) 3.6 3.7 NA
Neutrophils (109/l) 2.1 2.1 NA
CRP (mg/l) 0.3 0.3 0.3
Cortisol (nM) 311 NA 202
Blood pressure (mmHg, systolic/diastolic) 121/65 117/69 116/66
Heart rate (per min) 67 56 57
Temperature (°C) 35.7 36.4 36.9
Individual monitoring parameters for five volunteers (each recorded by an anonymized case identificiation number) receiving i.d. endotoxin in
the standardized endotoxin model. 0, Baseline observations prior to study start; 1, 1 h after endotoxin administration; 6, 6 h after endotoxin ad-
ministration; NA, data not available at that point.
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protein production by neutrophils was variable. Changes mea-
sured by this method failed to reach statistical significance
(Fig. 6), likely as a consequence of the smaller proportion of
cells staining positively in these sections. Thus, although these
data suggested clearly that neutrophils themselves are an im-
portant source of IL-1 during human inflammation, further
studies were required to test this further.
Neutrophils as a source of IL-1
To confirm the observations that neutrophils may be an im-
portant source of IL-1 in inflammation, we prepared highly
purified neutrophils by negative magnetic selection and stimu-
lated them with 100 ng/ml LPS for 4 h, a time-point compara-
ble with endotoxin exposure in our skin model. Analysis of the
resulting cell lysates revealed that human neutrophils activated
with LPS generated pro-IL-1 and processed it to its biologi-
cally active, 17-kDa form, in keeping with our observations in
the i.d. challenge model (Fig. 7).
Regulation of the intensity of neutrophilic
inflammation
Given ongoing production of CXCL8 and IL-1 in response to
endotoxin over time courses studied here, we were interested
to determine what factors limit neutrophil recruitment so that
the infiltration of neutrophils is matched to the size of the ini-
tiating inflammatory stimulus.
We examined to what extent neutrophils might, through the
well-established, rapid recycling of their principal chemokine
receptors CXCR1 and CXCR2 [17, 18], regulate amounts of
local CXCL8. Peripheral blood neutrophils were incubated
with various concentrations of CXCL8 (chosen so that the
minimum was around the Kd of the receptor [17–19].
In Fig. 8A, neutrophils (unprimed or primed with TNF-)
were incubated with varying concentrations of CXCL8 for 24
h. The amount of CXCL8 recoverable in supernatants after
this time was measured by ELISA. When CXCL8 was incubated
without neutrophils for 24 h in media, it did not show any
loss, as measured by ELISA (data not shown). However, where
CXCL8 was cultured with neutrophils for 24 h, the amount of
CXCL8 remaining in the cultures was reduced markedly, and
25% of even the highest concentration of CXCL8 remained
at this time. As tissue neutrophils are exposed to other proin-
flammatory stimuli that might alter their rates of receptor in-
ternalization and recycling, we exposed neutrophils to the
priming agents TNF- or GM-CSF (at doses found in separate
experiments to prime respiratory burst; data not shown) for 1
h prior to and continuing during the culture with CXCL8. Ex-
posure to either of these cytokines individually did not have
any effect on the rates of CXCL8 uptake by neutrophils over
the time course examined (Fig. 8). Neutrophils express
CXCL8 receptors, CXCR1 and CXCR2. Clearance of CXCL8
was significantly, although not completely, inhibited by prein-
cubation of neutrophils with blocking mAb to CXCR1 and
CXCR2 in combination (Fig. 8). A further hallmark of tissue
inflammation is local hypoxia at the site of injury, which is a
profound modulator of neutrophil function [20]. Exposure of
neutrophils to hypoxia (3 kPa pO2) did not modulate rates of
CXCL8 clearance (Fig. 8).
We next examined the potential ability of neutrophils to
mediate clearance of CXCL8 in well-characterized models of
airway inflammation established in our laboratory. In the first
model, epithelial cells were stimulated with the viral RNA
mimic, poly(I:C), in the presence of increasing numbers of
neutrophils. poly(I:C) causes the epithelial cells to generate
large amounts of CXCL8 and other cytokines [6]. Increasing
numbers of neutrophils added to the culture resulted in a
Figure 2. Inflammatory lesions induced by endotoxin. The figure shows representative images
from one volunteer of inflammation induced by endotoxin. Saline or endotoxin (5 ng) sites
are shown at 2 or 6 h as indicated. (A) Saline-injected site at 2 h; (B) 5 ng LPS-injected site at
2 h; (C) LPS 5 ng-injected site at 6 h. Ballpoint lines indicate erythema as demarcated by the
operator. Injection sites are marked by ballpoint arrows on the skin. (D) Mean areas of ery-
thema (expressed as mm2) at 2 and 6 h after endotoxin injection are shown on the accompa-
nying graph. In this graph, areas of erythema at 2 h were averaged within each volunteer from
two sites at each endotoxin dose, whereas at 6 h, data from a single site remained as the other
had been biopsied. Data displayed are n  5; mean  sem.
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marked decrease in the amount of detectable CXCL8 after 24
h (Fig. 9). These data indicate that CXCL8 uptake by neutro-
phils arriving at sites of viral infection has the potential to
markedly limit cytokine available for ongoing neutrophil re-
cruitment.
Other data have suggested that neutrophils may take up and
degrade IL-1 via expression of the decoy receptor IL-1R2
[21], which could limit inflammatory responses. We found
that in vitro, neutrophils did not take up detectable amounts
of IL-1 (data not shown). We therefore studied a more com-
plex in vitro inflammatory model with a marked IL-1 depen-
dence, modeling aspects of the initiation of response to bacte-
rial stimuli. BEAS-2B epithelial cells were cocultured with puri-
fied human CD14 monocytes and LPS. In this model of
endotoxin-induced inflammation, production of CXCL8 by
BEAS-2B cells is dependent on a network in which LPS acti-
vates the monocytes, releasing IL-1, which in turn, induces
CXCL8 production from the epithelial cells [22]. Addition of
neutrophils to this coculture again resulted in a reduction in
CXCL8 levels measured at 24 h, which was dependent on the
numbers of neutrophils added. In contrast to the model of
viral infection, CXCL8 levels were not reduced to baseline
(Fig. 9).
At sites of severe inflammation, e.g., in the ARDS, multi-
ple cytokines are generated and influence disease [23, 24].
Tissue neutrophils might also express other chemokine re-
ceptors, such as CCR2 [25]. We therefore exposed neutro-
phils to a mix of cytokines, CXCL8, CCL2 (the principal
ligand for CCR2), and IL-1, and for some cells, pretreated
them with a combination of TNF- and GM-CSF to mimic
the activation stimuli experienced in sites of severe inflam-
mation. In the absence of TNF- and GM-CSF, peripheral
Figure 3. Neutrophil recruitment in response to i.d. endotoxin. Volunteers
received i.d. injections of saline or endotoxin (5 or 15 ng/site), and sites
were biopsied at 2 or 6 h postinjection (6 h postinjection for the single-saline
site). Biopsies were stained for NE expression to measure neutrophil recruit-
ment. Illustrative staining of skin sites from a single volunteer are shown. Left
panels show representative photographs of staining at 200 magnification;
right panels show representative photographs taken at 600 magnification.
The identity of positive-staining cells as neutrophils is verified by their PMN
morphology on the cropped, enlarged inset image (Panel L). Original scale
bars indicate 100 m distances (200) and 50 m distances (600). Two
sections from each biopsy were quantified by automated image analysis, cal-
culating the percentage of NE staining across the whole section. Data from
the two sections were averaged for each subject and then the mean of n  5
calculated and displayed in K as mean  sem. The existence of a signifi-
cant dose-dependent response was tested by analysis using ANOVA
with Bonferroni’s post-test for selected comparisons, with significant
difference between the indicated pair shown by *P  0.05.
Figure 4. Peripheral blood cytokines after endotoxin challenge. Volun-
teers who had received i.d. endotoxin (total 40 ng/volunteer) had se-
rum cytokine levels measured by Meso Scale Discovery immunoassay at
baseline and 6 h after endotoxin challenge. Data shown are from four
of the five volunteers in the standardized component of the challenge
protocol, displayed as mean  sem; samples from one volunteer were
not available for analysis.
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Figure 5. i.d. cytokine generation after endotoxin challenge. Volun-
teers received i.d. injections of saline or endotoxin (5 or 15 ng/site),
and sites were biopsied at 2 or 6 h postinjection (6 h postinjection for
the single-saline site). Cytokine generation in the skin sites was mea-
sured by qPCR and presented as copies/g total RNA isolated from
biopsies. (A) CXCL8; (B) IL-1; (C) IL-1. Data are from four of the
five volunteers in the standardized component of the challenge proto-
col. Data displayed are mean  sem and were analyzed by ANOVA
with Tukey’s post-test, *P  0.05; **P  0.01; ***P  0.001, displaying
significant differences in expression versus the Time 0 control.
Figure 6. Expression of IL-1 in response to i.d. endotoxin. Volunteers re-
ceived i.d. injections of saline or endotoxin (5 or 15 ng/site), and sites were
biopsied at 2 or 6 h postinjection (6 h postinjection for the single-saline site).
Biopsies were stained for IL-1 expression. Illustrative staining of skin sites
from a single volunteer are shown. Left panels show representative photo-
graphs of staining at 200 magnification; right panels show representative
photographs taken at 600 magnification. The identity of positive-staining
cells as neutrophils is verified further by their PMN morphology on the
cropped, enlarged inset image (Panel L). Original scale bars indicate 100 m
distances (200) and 50 m distances (600). Two sections from each bi-
opsy were quantified by automated image analysis, calculating the percentage
of IL-1 staining across the whole section. Data from the two sections were
averaged for each subject and then the mean of n  5, sem, calculated and
displayed in K. Data are analyzed by ANOVA, but changes observed did not
reach statistical significance.
Basran et al. Neutrophil recruitment in the human
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blood neutrophils cleared CXCL8 (Fig. 10) from these cyto-
kine mixes, without reducing levels of CCL2 (Fig. 10) or
IL-1 (data not shown). Combined exposure to TNF- and
GM-CSF completely inhibited neutrophil uptake of CXCL8,
without activating uptake of CCL2 (Fig. 10) or IL-1 (data
not shown), suggesting that in some circumstances, neutro-
phil-mediated CXCL8 clearance may fail to contain inflam-
matory responses.
We considered whether release of ROS or chlorinating spe-
cies might modulate neutrophil uptake of CXCL8 or make
CXCL8 inaccessible to the ELISA through modification of the
proteins. We therefore incubated neutrophils with the NADPH
oxidase inhibitor DPI prior to incubation with CXCL8 or
TNF- and CXCL8. The data in Fig. 11 show that DPI pre-
treatment of neutrophils resulted in modest increases in de-
tectable remaining CXCL8 at the end of the experimental pe-
riod; however, this effect of DPI was only significant at one
point and was not more evident in the cells treated with
TNF-.
DISCUSSION
Considerable strides have been made describing the regulation
of leukocyte recruitment in animal models, but there are little
data examining the time course and mechanisms of neutrophil
recruitment in the human. Additionally, whereas the positive
stimuli regulating recruitment are becoming increasingly clear,
leukocyte recruitment at inflammatory sites is often rapidly
terminated [3], and the mechanisms responsible for the termi-
nation of recruitment of further cells to an active inflamma-
tory site are poorly understood.
We studied neutrophil recruitment induced in a skin model
where dose and time dependence could be investigated. We
determined that a preparation of endotoxin made for human
studies [8] activates TLR4 exclusively. i.d. injection of endo-
toxin induced a rapid, limited local inflammatory reaction,
with visible erythema preceding infiltration of neutrophils, and
CXCL8 mRNA generation was maximal at the earliest time-
point examined and diminished but not resolved over a 6-h
time course. In total, 13 volunteers received i.d. endotoxin at
various doses, with no significant adverse events recorded. The
dose chosen for the n  5 study group of 40 ng/volunteer to-
tal endotoxin corresponds to the amount of LPS obtained
from 16  106 E. coli [26].
Although total areas of inflammation were small, a number
of volunteers showed a rapid blood neutrophilia, demonstrat-
ing a remarkably sensitive ability of the innate immune system
to ready the human organism when bacterial infection may be
present. A search for mediators responsible for this blood neu-
trophilia in serum using sensitive immunoassays failed to iden-
tify a likely candidate. Neutrophil recruitment was associated
with local generation of CXCL8. We were intrigued about the
nature of mechanisms matching neutrophil recruitment to the
magnitude of the inflammatory stimulus. One mechanism
would be a graded induction of chemokines such as CXCL8,
with small stimuli producing little chemokine and large stimuli
causing the production of large amounts of mediators. How-
ever, seminal work in rabbit models of pneumonia indicates
that neutrophil recruitment occurs early in the pathology and
is terminated before maximal activation is seen at the inflam-
matory site [3, 4]. Induction of proresolution environments
through resolvin expression [27] or neutrophil apoptosis [28]
would be unlikely to be active during initiation of recruitment
and would be poor pathways to regulate early recruitment, as
they would inhibit subsequent effective neutrophil activation.
The simplest regulatory system would be if neutrophils them-
selves could sense the size of the inflammatory response and
terminate ongoing cell recruitment by receptor-mediated
clearance of CXCL8. We observed that neutrophils were able
to mediate a sustained clearance of CXCL8 from their sur-
roundings. Blockade of CXCR1 and CXCR2 inhibited CXCL8
clearance significantly but incompletely. Thus, ligand clear-
ance is at least in part receptor-dependent, despite the well-
characterized, rapid process of receptor desensitization, that
down-regulates internalization of ligand-exposed CXCR1 and
CXCR2 [29–31]. Neutrophils express 20,000–50,000 CXCR1/2
molecules/cell [17], and exposure of 0.5 million neutrophils
to 8 nM CXCL8 in the experimental volume studied repre-
Figure 7. Production of IL-1 by neutrophils. Highly purified human
neutrophils from healthy control patients were treated with 100 ng/ml
LPS for 4 h. Whole cell lysates were analyzed by Western blot using
antibodies specific to IL-1 and total p38 MAPK as a loading control.
(A) Data from three independent donors. D1–D3, Days 1–3. The 17-
kDa bands, corresponding to cleaved, mature IL-1, were analyzed by
densitometry and displayed in B. Data are presented as mean  sem
of n  3. Significant differences are indicated by *P  0.01, as ana-
lyzed by paired t test.
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sented 100 molecules of CXCL8/receptor. This scavenging
system was selective, with no removal of CCL2 from media by
neutrophils. The failure of CXCR1/2 blockade to inhibit
CXCL8 clearance completely could suggest that neutrophil
protease release is also occurring and potentially breaking
down CXCL8, although our experiments were conducted in
10% FCS, which contains many potent antiproteases. We con-
sidered whether products of NADPH oxidase might modulate
neutrophil CXCL8 uptake through regulation of neutrophil
priming [32] or make CXCL8 inaccessible to ELISA through
covalent modification. The NADPH oxidase inhibitor DPI, at
the top concentration tested at 20 M, modestly reduced the
measured CXCL8 loss seen when CXCL8 was incubated with
unprimed neutrophils. However, the ability to clear CXCL8
from our cultures of TNF--primed neutrophils was not signifi-
cantly susceptible to NADPH oxidase inhibition, despite the
fact that TNF- treatment might be expected to up-regulate
NADPH oxidase activity. We believe overall that it is most
likely that the failure of CXCR1/2 blockade to fully neutralize
CXCL8 clearance therefore reflects incomplete blockade of all
cell surface receptors, but it remains possible that other mech-
anisms can contribute to neutrophil-driven CXCL8 clearance.
Our data showed that CXCL8 clearance is robust and not
inhibited by single priming agents or by hypoxia (a potent
neutrophil survival factor at inflammatory loci) [20, 33]. These
data are striking, given that hypoxia/reperfusion regulates
CXCR1 expression [34], and GM-CSF and TNF- can each
regulate CXCR1/2 expression [35–37]. TNF-- and GM-CSF-
induced IL-8R down-regulation is potentiated by endotoxin
[35] and for TNF-, involves mechanisms, including metallo-
proteinase-mediated receptor shedding [36]. Therefore, de-
spite the potential for CXCL8 receptor down-regulation in in-
flammatory environments, enough residual receptor function
remained in these experiments to clear substantial quantities
Figure 8. Uptake of CXCL8 by neutrophils. Highly purified human neutrophils (0.5106/point) were prepared and incubated with various con-
centrations of CXCL8 for 24 h, after which, remaining CXCL8 was quantified by ELISA. Incubation of CXCL8 in media alone without neutrophils
for 24 h did not reduce amounts of recoverable CXCL8 (data not shown). (A and B) Neutrophils were also primed with 10 ng/ml TNF- (A) or
50 U/ml GM-CSF (B) for 1 h prior to addition of CXCL8 for 24 h (the priming agents remained present throughout the time course). (C) Neu-
trophils were preincubated with media, a control IgG, or blocking mAb to CXCR1- or CXCR2-neutralizing antibodies, alone or in combination for
30 min, followed by the addition of CXCL8 (8.3 nM) for 24 h. (D) Neutrophils were cultured with CXCL8 at the indicated concentrations under
normoxic or hypoxic (pO2 3 kPa) conditions for 1, 4, and 24 h. In all experiments, at the required time-points, cell-free supernatants were gener-
ated and CXCL8 levels measured by ELISA. Data are presented as percentage CXCL8 remaining in the supernatant and are mean  sem (n4, A
and B; n3–5, C and D), with each replicate performed with freshly prepared neutrophils from independent donors. (C) Data were analyzed by
one-way ANOVA and Tukey’s post-test. Significant differences are indicated by *P  0.05.
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of CXCL8. Consistent with this, CXCR1 function is maintained
in neutrophils from patients with sepsis [38]. However, treat-
ment of neutrophils with combinations of priming agents
caused cessation of CXCL8 clearance. It is most likely that this
reflects enhanced down-regulation of CXCR1/2 surface ex-
pression and function through the mechanisms noted above.
These data generate two further hypotheses. The first is that
simple inflammatory networks can regulate the way the neutro-
phil behaves with respect to modulating further cellular re-
cruitment. Neutrophils have limited efficacy against viruses yet
are commonly recruited to the lungs with respiratory virus in-
fection. In our model of airways viral infection, neutrophils
rapidly cleared CXCL8 and might thus be expected to limit
neutrophil recruitment in a setting in which the neutrophil
has an uncertain role. However, in our model of bacterial air-
ways infection, neutrophil-mediated CXCL8 clearance was less
effective. This may be important in vivo, as CXCL8 activates
bacterial killing by neutrophils [39], and persistent CXCL8
levels are likely to enable a greater total neutrophil recruit-
ment to bacterial infection. Limitations on CXCL8 clearance
Figure 9. Clearance of CXCL8 from models of inflammation. BEAS-2B
epithelial cells were grown to 95% confluence in 24-well plates. In a
model of viral inflammation (A), cells were stimulated with poly(I:C)
at 10 g/ml in the absence or presence of neutrophils at the indi-
cated numbers for 24 h. Cell-free supernatants were generated, and
CXCL8 in the supernatants was measured by ELISA. Data shown are
mean  sem (n3), with each replicate performed on separate pas-
sages of BEAS-2B cells with freshly prepared neutrophils from inde-
pendent donors. In a model of bacterial infection (B), BEAS-2B epi-
thelial cells were cultured alone or cocultured with CD14 monocytes
(monos). Cultures were stimulated with LPS (1 ng/ml) in the pres-
ence of the indicated numbers of neutrophils for 24 h. Cell-free super-
natants were generated, and CXCL8 release was measured by ELISA.
Data shown are mean  sem (n6), with each replicate performed on
separate passages of BEAS-2B cells with freshly prepared monocytes
and neutrophils from independent donors. Data were analyzed by
one-way ANOVA with Dunnett’s post-test, with significant differences
indicated by *P  0.05; **P  0.01; and ***P  0.001.
Figure 10. Clearance of cytokines from mixed cultures. Highly puri-
fied human neutrophils (0.5106/point) were obtained and pre-
treated with media or TNF- (10 ng/ml) and GM-CSF (50 U/ml) in
combination for 1 h. Following this, treated neutrophils were incu-
bated with increasing concentrations of CXCL8, MCP-1, and IL-1 in
combination for 24 h (in the ongoing presence of TNF- and GM-CSF
if added). Cell-free supernatants were generated, and CXCL8 (A),
CCL2 (B), and IL-1 (data not shown) levels were measured by
ELISA. Data are presented as percentage of CXCL8 or CCL2 remain-
ing in the supernatant and are mean  sem (n3), with each repli-
cate performed with freshly prepared neutrophils from independent
donors. Data were analyzed by two-way ANOVA and Bonferroni’s post-
test. Significant differences are indicated by **P  0.01.
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in bacterial infections may be mediated by direct actions of
endotoxin on rates of CXCR1/2 recycling [35], indirect ac-
tions of monocyte-derived cytokines [10], or release of excess
neutrophil proteases that can cleave CXCR1 [39]. In our skin
model, some punctate noncell-associated NE staining was ob-
served in challenged sites. This is consistent with degranula-
tion of neutrophils in response to diffuse local exposure to
LPS, and therefore, even in this resolving model of limited
inflammation, there is potential for NE to modify local CXCL8
clearance through CXCR1 cleavage. Other mechanisms exist
that will also contribute to regulation of cell recruitment.
These include the temporal regulation of selectin expression
at inflammatory sites [40] and the clearance of chemokines in
the circulation and lymphatics, which our in vitro models can-
not measure, but our data suggest that neutrophil-mediated
clearance of CXCL8 has the potential to be an important reg-
ulator of inflammation in vivo. A second hypothesis gener-
ated by our observations is that persistent neutrophilic in-
flammatory disease may at least in part represent a failure
of tissue neutrophils to regulate local CXCL8 levels, conse-
quent upon excessive local generation of proinflammatory
mediators, which are well-defined features of conditions
such as ARDS [23].
We have shown previously that responses of tissue cells to
LPS are markedly amplified in the presence of monocytes
through their generation of local IL-1 [5, 6, 14, 22], findings
that are relevant to animal models of lung [41] and skin in-
flammation [42, 43]. In our human model, expression of
IL-1 correlated with appearance of neutrophils in the skin,
IL-1-expressing cells showed the typical nuclear morphology
of neutrophils, and we found highly purified neutrophils
could produce and process IL-1 in vitro. Expression of IL-1
mRNA has also been observed in neutrophils recruiting in
skin windows to nonmicrobial chemoattractants [44]. A central
role for IL-1 in the initiation of inflammation is well estab-
lished; normally, the presence of neutrophils is taken to indi-
cate that this process is well underway, but these data indicate
that in the human, the neutrophil may itself have the poten-
tial to amplify inflammation. This is consistent with recent
work in a mouse arthritis model, where neutrophils express
IL-1 and deliver this to the joint [2], and this may be essential
in the later recruitment of monocytes/macrophages to the in-
flammatory site [45]. Our in vitro assays showed that quiescent
and primed neutrophils failed to reduce the local concentra-
tion of IL-1. This observation contradicts one study which
showed that neutrophils could take up 50% of a local con-
centration of radiolabeled IL-1 [21], although we studied
highly purified neutrophils, having removed contaminating
monocytes that modulate neutrophil responses to IL-1 [46].
These data once again emphasize the potential for indepen-
dent regulation of components of the neutrophilic inflamma-
tory response, as neutrophils appear to be able to limit local
CXCL8 but not IL-1 concentrations by receptor-mediated
uptake.
In conclusion, we have shown that neutrophils are rapidly
recruited to sites of inflammation in the human. Rapid gener-
ation of CXCL8 at sites of inflammation is associated with re-
cruitment of neutrophils, which may themselves be an impor-
tant source of proinflammatory mediators such as IL-1. We
have described mechanisms showing how neutrophil recruit-
ment may be regulated at sites of inflammation that may be-
come dysregulated in disease.
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